| Literature DB >> 36035671 |
Rong Chen1,2, Yuheng Liu1, Shu Chen1, Ming Wang1, Yao Zhu1, Tianyuan Hu1, Qiuhui Wei1, Xiaopu Yin1, Tian Xie1.
Abstract
Germacrene A (GA) is a key intermediate for the synthesis of medicinal active compounds, especially for β-elemene, which is a broad-spectrum anticancer drug. The production of sufficient GA in the microbial platform is vital for the precursors supply of active compounds. In this study, Escherichia coli BL21 Star (DE3) was used as the host and cultivated in SBMSN medium, obtaining a highest yield of FPP. The GA synthase from Lactuca sativa (LTC2) exhibited the highest level of GA production. Secondly, two residues involved in product release (T410 and T392) were substituted with Ser and Ala, respectively, responsible for relatively higher activities. Next, substitution of selected residues S243 with Asn caused an increase in activity. Furthermore, I364K-T410S and T392A-T410S were created by combination with the beneficial mutation, and they demonstrated dramatically enhanced titers with 1.90-fold and per-cell productivity with 5.44-fold, respectively. Finally, the production titer of GA reached 126.4 mg/L, and the highest productivity was 7.02 mg/L.h by the I364K-T410S mutant in a shake-flask batch culture after fermentation for 18 h. To our knowledge, the productivity of the I364K-T410S mutant is the highest level ever reported. These results highlight a promising method for the industrial production of GA in E. coli, and lay a foundation for pathway reconstruction and the production of valuable natural sesquiterpenes.Entities:
Keywords: germacrene A; germacrene A synthase; host optimization; site-directed mutagenesis; β-elemene
Year: 2022 PMID: 36035671 PMCID: PMC9403833 DOI: 10.3389/fpls.2022.932966
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
SCHEME 1Biosynthesis of germacrene A and its precursors. FPP is produced from acetyl-CoA through the MVA pathway and then form β-elemene or other sesquiterpene lactones (A). The plasmids pBbA5c-MM and pET28a-GASs (B).
Plasmids, strains, and primers used in this study.
| Plasmids, strains and primers | Description | Source or reference |
|
| ||
| pET-28a | Integrative plasmid, kan | Library stock |
| pET-28a-LTC2 | kan | This study |
| pET-28a-CbGAS | kan | This study |
| pET-28a-HbSAS | kan | This study |
| pET-28a-FtSAS | kan | This study |
| pET-28a-MmGDS | kan | This study |
| pET-28a-NpGAS | kan | This study |
| pET-28a-CmGAS | kan | This study |
| pET-28a-CfGAS | kan | This study |
| T410S | kan | This study |
| T410V | kan | This study |
| T410A | kan | This study |
| T392A | kan | This study |
| T392V | kan | This study |
| T38S | kan | This study |
| L58V | kan | This study |
| A229S | kan | This study |
| S243N | kan | This study |
| I364K | kan | This study |
| I492K | kan | This study |
| S243N-T410S | kan | This study |
| I364K-T410S | kan | This study |
| T392A-T410S | kan | This study |
| T392V-T410S | kan | This study |
| NKS | kan | This study |
| KAS | kan | This study |
| pBbA5c-MM | Cm |
|
|
| ||
| F–
| Tsingke Co. | |
| F–
| Tsingke Co. | |
| F–, DE( | Huayueyang Co. | |
| Weidi Co. | ||
| F–
| Huayueyang Co. | |
|
| ||
| T410-F | aaaatggtctgattnbwgcgcatataatg | This study |
| T410-R | wvnaatcagaccattttttcatattccgg | This study |
| T392A/V-F | agaagcagaatgggynaatagcgttatg | This study |
| T392A/V-R | nrcccattctgcttcttccagataaccacg | This study |
| T38S-F | gatcgttttctgagctttagcctggataat | This study |
| T38S-R | ctaaagctcagaaaacgatcaccccaaa | This study |
| L58V-F | aagcaccgaaagaagaagtgcgtcgtct | This study |
| L58V-R | cttcttctttcggtgcttccattgcttttgcat | This study |
| A229S-F | ttatagcgaagaatgtagcacccatgaat | This study |
| A229S-R | gctacattcttcgctataattgctaaaatac | This study |
| S243N-F | ctggcaaaactgcattttaactatctggaact | This study |
| S243N-R | ttaaaatgcagttttgccagtttcagcagac | This study |
| I364K-F | aaaaacagctggcaaaagaaggtcgtg | This study |
| I364K-R | ttttgccagctgtttttccagttctgcat | This study |
| I492K-F | gcaattgatgaactgaaaaaaatgattgaaa | This study |
| I492K-R | ttttttcagttcatcaattgcttctttttcgc | This study |
FIGURE 1Effect of medium and strains on farnesol yield and OD600 in E. coli hosts carrying pMM.
FIGURE 2GC-MS analysis of products in E. coli BL21Star (DE3) pMM- GASs. Peaks 1, β-elemene; 2, guaiene; 3, sativene; 4, germacrene D.
FIGURE 3β-elemene titer and OD600 analysis of E. coli BL21Star (DE3) pMM- GASs.
FIGURE 4The relative yields of T410 and T392 mutants compared with WT.
The selected residue positions in LTC2 and plant-derived GASs.
| Amino acid position | |||||||
| Species | Name | 38 | 58 | 229 | 243 | 364 | 492 |
|
| LTC2 | T | L | A | S | I | I |
|
| BsGAS1 | S | V | S | N | K | K |
| HaGAS1 | S | V | S | N | K | K | |
| HaGAS2 | S | V | S | N | K | K | |
|
| CiGASsh | S | V | S | N | K | K |
| CiGASlo | S | V | S | N | K | K | |
|
| ToGAS2 | S | V | S | N | K | K |
FIGURE 6The relative yields of LTC2 double mutants compared with WT.
FIGURE 7The titer (A) and per-cell productivity (B) of β-elemene in E. coli BL21 Star (DE3) pMM – LTC2 mutants.
FIGURE 8The overview structure of LTC2 and mutant residues (A); LTC2-FPP interaction and active channel (B).
Comparison of data for the production of β-elemene in engineered strains.
| Chassis | GAS | Titer (mg/L) | Time (h) | Productivity (mg/L h) | References |
|
| AvGAS-F23V | 309.8 | 72 | 4.30 |
|
|
| LTC2 | 190.7 | 72 | 2.65 |
|
|
| LTC2 | 469 | 144 | 3.26 |
|
|
| LTC2-I364K-T410S | 126.4 | 18 | 7.02 | This research |